RSS

commercial production

In this article Robert L. Moore, PhD, from Cryoport Services discusses the key considerations of manufacturing biologics in a commercial environment and the benefits of intelligent logistics. Read more

Opinion

TiGenix has obtained a licence for the commercial production of expanded adipose-derived stem cells (eASCs) at its expanded manufacturing facility in Madrid, Spain, following an inspection by the Spanish Medicines Agency (AEMPS). Read more

News

GEA Process Engineering’s pharmaceutical GMP spray drying facility in Copenhagen, Denmark, has been granted authorisation by the Danish Health and Medicines Authority for spray drying of human medicinal products for commercial use. The company’s... Read more

Technology

Aesica’s High Capacity Manufacturing facility has been validated for commercial production; $45 million (€32.4/£27 million) has been invested at its Queenborough, UK, site. Read more

Technology

Addressing client demand to ease the transition between clinical and commercial launch for blister products, Almac has added new blistering technology at its US commercial packaging facility in Audubon, Pennsylvania. Read more

Technology

With the opening of a new commercial packaging facility in the US and enhanced processing capabilities at the company’s Headquarters in Craigavon, UK, investments in the past year has substantially transformed the commercial business unit of Almac. Read more

Technology

Following the success of one of its key client partnered products, Almac, based in Craigavon, UK, has announced a commercial manufacturing expansion. Together with the recent completion of a new non-GMP drug development facility at the Craigavon... Read more

Technology

PCI has announced the appointment of Tim Roberts to Associate Director of Clinical Trials. The changes follow the restructure of its global management announced last year and recent acquisition of AndersonBrecon. Read more

Technology

Microspheres are small spherical particles, having a required size range (typically 5 up to 250 μm). These particles can be manufactured from various natural and synthetic materials such as polymer microspheres. New applications for microspheres... Read more

Technology

SCM Pharma’s new £6 million contract manufacturing facility has been given the go ahead for commercial production following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA). Read more

Technology